- Analytics
- Backtesting
- Options
- Resources
Best-in-market backtesting with 4+ years of data, payoff charts, and auto-play
Nifty, Bank Nifty, Finnifty, Midcap Nifty, Sensex
Test your intraday trading strategies with historical tick data
Nifty, Bank Nifty, Finnifty, Midcap Nifty
Find market trends with high accuracy, includes historical data analysis
NSE, BSE, MCX Commodities
Find market momentum with calls vs puts comparison across strikes
Nifty, Bank Nifty, Finnifty, Sensex
Backtest intraday market, find today's market trend with complete OI flow
Nifty, Bank Nifty, Finnifty, Midcap Nifty, Sensex, MCX Commodities
.svg){kind=small}
.svg){kind=small}
.svg){kind=small}
.svg){kind=small}
Sahajanand Medical Technologies IPO
Sahajanand Medical Technologies IPO
Overview
Sahajanand Medical Technologies IPO is a book build issue of ₹475.48 crores. The issue is entirely an offer for sale of 1.38 crore shares of ₹475.48 crore. Sahajanand Medical Technologies IPO opens for subscription on Oct 15, 2026 and closes on Oct 19, 2026. The allotment for the Sahajanand Medical Technologies IPO is expected to be finalized on Oct 21, 2026. Sahajanand Medical Technologies IPO will list on NSE and BSE with a tentative listing date fixed as Oct 23, 2026. Sahajanand Medical Technologies IPO is set issue price band at ₹327 to ₹344 per share. The lot size for an application is 43 shares. The minimum amount of investment required by an individual investor (retail) is ₹14,792 (43 shares) (based on upper price). Motilal Oswal Investment Advisors Ltd. is the book running lead manager and MUFG Intime India Pvt.Ltd. is the registrar of the issue.
Total Shares
1,38,22,116
Issue Size
₹475 Cr
Price Band
₹327 – ₹344
Lot Size
43 shares
Min. Investment
₹14,792
Max. Investment
₹1,92,296
Open Date
15 Oct, 2026
Close Date
19 Oct, 2026
Allotment
21 Oct, 2026
Listing
23 Oct, 2026
Max. Investment
₹1,92,296
Announced
15 Oct, 2026
Opening Date
15 Oct, 2026
Closing Date
19 Oct, 2026
Basis of Allotment
21 Oct, 2026
Initiation of Refunds
22 Oct, 2026
Credit of Shares
22 Oct, 2026
Listing Date
23 Oct, 2026
Live GMP
Est. Listing: ₹359
Apply via UPI in 5 minutes
Choose your broker • Zero commission on IPO
About Sahajanand Medical Technologies IPO
Founded in 2001 by Mr. Dhirajlal Kotadia, Sahajanand Medical Technologies Ltd. is a medical device company focused on Class III and Class C/D devices, primarily in the fields of vascular and structural heart intervention. The company was the first globally to receive CE certification for a drug-eluting stent (DES) with a biodegradable polymer—Infinnium.
The product portfolio spans three key categories:
- Vascular Intervention (VI): Includes coronary stents and
Sahajanand Medical Technologies IPO Share Price
Issue Breakdown
Shareholding
Dilution: 0.0% increase in shares
Sahajanand Medical Technologies IPO Financial Health
Sahajanand Medical Technologies Ltd.'s revenue increased by 18% and profit after tax (PAT) rose by 175% between the financial year ending with March 31, 2026 and March 31, 2025.
Sahajanand Medical Technologies IPO Lot Size
Investors can bid for a minimum of 43 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 43 | ₹14,792 |
| Retail (Max) | 13 | 559 | ₹1,92,296 |
| S-HNI (Min) | 14 | 602 | ₹2,07,088 |
| S-HNI (Max) | 67 | 2881 | ₹9,91,064 |
| B-HNI (Min) | 68 | 2924 | ₹10,05,856 |
(All values in CR)
Sahajanand Medical Technologies IPO Valuations
| Metric | Value |
|---|---|
| ROE | 2.07 |
| ROCE | 3.16 |
| Debt/Equity | 0.33 |
| RoNW | 2.31 |
| PAT Margin | 4.29 |
| EBITDA Margin | 13.81 |
| NAV | 64.35 |
(All values in CR)
Sahajanand Medical Technologies IPO Strength & Risk
Sahajanand Medical Technologies IPO Strength
Strong presence in the cardiovascular medical-device industry.
Specialised product portfolio, including coronary stents and balloons.
Research and development capabilities supporting product innovation.
Established international market presence and export opportunities.
Revenue and profit growth reported in FY2026.
Potential to benefit from rising demand for advanced cardiovascular treatments.
Sahajanand Medical Technologies IPO Risk
Significant revenue dependence on its flagship Supraflex Cruz stent.
Strict regulatory requirements for medical-device manufacturing and sales.
High supplier concentration, creating potential supply-chain risks.
Rising borrowings that may increase financial pressure.
Intense competition from domestic and international medical-device manufacturers.
IPO valuation risk and no fresh capital raised for business expansion through the reported offer-for-sale structure.
Sahajanand Medical Technologies IPO Subscriptions Status
Sahajanand Medical Technologies IPO subscribed 2.53 times. The public issue subscribed 1.84 times in the retail category, 1.70 times in QIB (Ex Anchor), and 5.52 times in the NII category by October 19, 2026 2:18:52 PM (Day 3).
| Investor Category | Subscription (times) | Shares Offered | Shares bid for | Total Amount (Rs Cr.) |
|---|---|---|---|---|
| Anchor | 1.00 | 40,71,634 | 40,71,634 | 140.064 |
| QIB (Ex Anchor) | 1.70 | 27,14,424 | 46,23,575 | 159.051 |
| NII | 5.52 | 20,35,817 | 1,12,38,050 | 386.589 |
| bNII (> ₹10L) | 5.95 | 13,57,212 | 80,71,229 | 277.65 |
| sNII (< ₹10L) | 4.67 | 6,78,606 | 31,66,821 | 108.939 |
| Retail | 1.84 | 47,50,241 | 87,33,558 | 300.434 |
| Employees | 0.26 | 2,50,000 | 65,231 | 2.244 |
| Total | 2.53 | 97,50,482 | 2,46,60,414 | 848.318 |
Sahajanand Medical Technologies IPO GMP
Sahajanand Medical Technologies IPO last recorded Grey Market Premium (GMP) is ₹15, updated on Oct 19, 2026 01:02:02 PM. With an upper price band of ₹344.00, the estimated listing price for Sahajanand Medical Technologies IPO is ₹359 (cap price + today's GMP). This indicates an expected listing gain for Sahajanand Medical Technologies IPO of 4.36%. • Sahajanand Medical Technologies IPO Retail Subject to Sauda: ₹500 • Sahajanand Medical Technologies IPO Small HNI Subject to Sauda: ₹7000 During this period, the premium has fluctuated between a low of ₹15.00 and a high of ₹43.00.
Last updated 19 Oct, 2026 · Source: aggregated grey-market dealers
| Date | IPO Price | GMP | Sub2 Sauda | Est. Listing | Est. Profit | Updated |
|---|---|---|---|---|---|---|
| 19 Oct, 2026 | 0 | ₹15▼ | - | ₹359 (4.36%) | 645 | 19 Oct, 2026 |
| 18 Oct, 2026 | 0 | ₹25▲ | - | ₹369 (7.27%) | 1075 | 18 Oct, 2026 |
| 17 Oct, 2026 | 0 | ₹15▼ | - | ₹359 (4.36%) | 645 | 17 Oct, 2026 |
| 16 Oct, 2026 | 0 | ₹35▼ | - | ₹379 (10.17%) | 1505 | 16 Oct, 2026 |
| 15 Oct, 2026 | 0 | ₹43▲ | - | ₹387 (12.50%) | 1849 | 15 Oct, 2026 |
| 14 Oct, 2026 | 0 | ₹41 | - | ₹385 (11.92%) | 1763 | 14 Oct, 2026 |
| 13 Oct, 2026 | 0 | ₹41▲ | - | ₹385 (11.92%) | 1763 | 13 Oct, 2026 |
| 12 Oct, 2026 | 0 | ₹35▼ | - | ₹379 (10.17%) | 1505 | 12 Oct, 2026 |
| 11 Oct, 2026 | 0 | ₹40 | - | ₹40 (0.00%) | - | 11 Oct, 2026 |
Disclaimer: GMP is an unofficial signal from grey-market dealers and is not regulated by SEBI. Use it alongside subscription data and other research for informed decision-making.
How to Apply for Sahajanand Medical Technologies IPO
Login to Your Trading App
Open Zerodha, Upstox, Groww, Angel One, or any brokerage app.
Go to IPO Section
Find Sahajanand Medical Technologies IPO under the IPO section. Select it and enter your bid details — choose lot size and price (cut-off price recommended).
Enter UPI ID and Submit
Provide your UPI ID linked to your bank account and submit the application.
Approve Mandate on UPI App
Open your UPI app (Google Pay, PhonePe, Paytm, BHIM) and approve the IPO payment request.
Application Confirmed
Your funds will be blocked in your account until the IPO allotment process is completed.
India's most-trusted pre-market & options analytics platform.
Subscribe to our newsletter
Sign up & receive the latest tips via email.
IMPORTANT LINKS
TOOLS
Copyright © NiftyTrader · All rights reserved · ver 1.4.1